Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
Abroad (travel likely)Recruiting
Conditions
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · NAFLD - Non-Alcoholic Fatty Liver Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Washington, Seattle, Washington, United States
Contact: Principal Investigator (Rotonya Carr, MD)Contact: Principal Investigator (Manish Dhyani, MD)